Top brokers name 3 ASX shares to buy next week

Brokers are feeling bullish on these ASX shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last week saw a number of broker notes hitting the wires once again. Three buy ratings that investors might want to be aware of are summarised below.

Here's why brokers think investors ought to buy them next week:

Broker written in white with a man drawing a yellow underline.

Image source: Getty Images

Aristocrat Leisure Limited (ASX: ALL)

According to a note out of Citi, its analysts have retained their buy rating and $41.20 price target on this gaming technology company's shares. Citi has analysed digital bookings data to December and is happy with what it saw. It highlights that bookings lifted on a seasonal Christmas boost last month and that Aristocrat's Pixel United business continues to outperform. The Aristocrat share price ended the week at $33.20.

Coronado Global Resources Inc (ASX: CRN)

A note out of Goldman Sachs reveals that its analysts have retained their buy rating and lifted their price target on this coal miner's shares to $2.25. The broker made the move after looking at the mining sector. It believes Coronado Global is a top option for investors looking for met coal exposure following China's reopening. Particularly if you're looking for dividends. Goldman is expecting strong met coal prices to allow the company to pay a 21.9 US cents per share dividend in FY 2023. This equates to a 15.5% yield at current prices and exchange rates. The Coronado Global share price was fetching $2.03 at Friday's close.

Macquarie Group Ltd (ASX: MQG)

Analysts at Morgan Stanley have retained their overweight rating and $215.00 price target on this investment bank's shares. The broker believes that Macquarie is well-placed to benefit from volatility in commodity markets. Particularly given that approximately a third of its revenue comes from its commodities business. The Macquarie share price ended the week at $178.27.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Two work colleagues looking at a laptop and discussing something.
Broker Notes

Three ASX shares set to rise up to 47% – Expert

These ASX shares were earnings results winners.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

This ASX 200 gold stock could be a top buy after a 'transformational' year

Bell Potter is bullish on this name. Let's find out why.

Read more »

Woman analysing data.
Broker Notes

What is Bell Potter saying about EOS shares after its results?

The broker remains bullish on this rapidly growing stock.

Read more »

Happy man on a supermarket trolley full of groceries with a woman standing beside him.
Broker Notes

Are Coles shares a buy after its results?

Bell Potter has given its view on the supermarket giant.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

3 ASX shares Macquarie says will return 23% to 49%

These shares are well-positioned for a strong year.

Read more »

Woman and man at work looking at data on a tablet at work.
Broker Notes

Buy, hold, sell: Judo Capital, Healius, BHP shares

Morgans has issued new notes on several stocks including BHP, which hit a new record today.

Read more »

Woman with her kitten on a laptop in her home office.
Broker Notes

Buy, hold, sell: Bendigo and Adelaide Bank, PLS, EOS shares

These three ASX shares posted their FY26 results this week. Find out what brokers tip next.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Bell Potter says this ASX biotech could nearly double in value

The US market is starting to open up for this company.

Read more »